3D Orthobiologic Solutions (3DOS)

3DOS is revolutionizing oral and maxillofacial surgery by utilizing biomaterials and 3D printing to address segmental bone defects in the jaw. The company's mission is to enable patients to regain natural aesthetics and functionality through efficient bone regeneration, essential for dental implant placement.

Founded in 2019, 3DOS offers a groundbreaking alternative to current treatment options for bone defects, such as autografts, allografts, and synthetic materials with rigid metal fixation, which are expensive and involve prolonged recovery periods.

The company's innovative solution reduces costs by up to 50% and significantly minimizes the need for traditional methods, thereby lowering operating room time by almost half. Moreover, it precisely matches defect geometry and accelerates recovery time to six months or less compared to the standard year-long duration.

3DOS's customizable, 3D-printed scaffold is designed to optimize bone regrowth while ensuring biocompatibility and compatibility with existing 3D printing machines, ultimately enhancing speed, quality, and cost-efficiency. The company recently secured a $20.00K grant investment from Lighthouse Labs RVA in February 8, 2024.

This investment will fuel the company's efforts to further develop and promote its biodegradable scaffold, offering a high-throughput option for oral surgeons and paving the way for significant advancements in the field of oral and maxillofacial surgery.